Qin X. Inactivation of digestive proteases: Another aspect of gut bacteria that should be taken into more consideration. World J Gastroenterol 2007; 13(16): 2390-2391 [PMID: 17511046 DOI: 10.3748/wjg.v13.i16.2390]
Corresponding Author of This Article
Xiaofa Qin, MD, PhD, Department of Surgery, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103, United States. qinxi@umdnj.edu
Article-Type of This Article
Letters To The Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Xiaofa Qin, Department of Surgery, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103, United States
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Xiaofa Qin, MD, PhD, Department of Surgery, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103, United States. qinxi@umdnj.edu
Telephone: +1-973-9722896 Fax: +1-973-9726803
Received: February 5, 2007 Revised: March 3, 2007 Accepted: April 16, 2007 Published online: April 28, 2007
Abstract
Key Words: $[Keywords]
Citation: Qin X. Inactivation of digestive proteases: Another aspect of gut bacteria that should be taken into more consideration. World J Gastroenterol 2007; 13(16): 2390-2391
Protein has been one of the main components of our diet, and a large amount of digestive proteases is released into the gut for their digestion. However, these proteases can digest not only the proteins we eat, but also the structural proteins built in our body. To protect against this damage, our body has taken a variety of measures. For instance, these digestive proteases are stored and secreted in the form of zymogen and only activated in gut lumen[1]. These luminal digestive proteases are further prevented from direct contact with epithelial cells by the mucus layer that is incessantly secreted by the goblet cells in gut mucosa[2]. In addition, large quantities of protease inhibitors are produced in the body to inactivate the digestive proteases that have entered the body[3]. Despite these measures, the protection seems still weak and can be easily compromised. For instance, studies have well shown that pancreatic proteases play a critical role in mucosal damage induced by hemorrhagic and endotoxic shock[4,5], ischemia-reperfusion[6,7], stress[5], acute radiation[8], or agents such as indomethacin[9], ibuprofen[10], or oleic acid[11]. Gut damage can be greatly alleviated by inhibition of these digestive proteases[4,6], ligation of the pancreatic duct[12,13], or pancreatectomy[14]. Conversely, intraluminal injection of trypsin aggravates the lesion of the mucosa[15]. Therefore, a prompt inactivation of these digestive proteases may play an important protective role against this digestive damage. Under conventional condition, digestive proteases are effectively inactivated at the lower intestine, which depends on certain kinds of bacteria in the gut[16,17]. An inhibition of gut bacteria by factors such as saccharin, and the resulting impairment in protease inactivation and over-digestion of the mucosa may play a causative role in IBD[18,19]. It may also contribute to the increased intestinal permeability and the development of many other autoimmune and allergic diseases such as multiple sclerosis, typeIdiabetes, asthma, and atopic dermatitis, which seem to be associated with improved hygiene condition and reduced bacteria exposure[20]. Therefore, besides the immune regulatory and toxic effect of gut bacteria on the host, the role of gut bacteria in protease inactivation would be another aspect that should be taken into consideration.
Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo.Am J Physiol Gastrointest Liver Physiol. 2001;280:G922-G929.
[PubMed] [DOI]
Bounous G, Menard D, De Medicis E. Role of pancreatic proteases in the pathogenesis of ischemic enteropathy.Gastroenterology. 1977;73:102-108.
[PubMed] [DOI]
Kimura RE, Arango V, Lloyd-Still J. Indomethacin and pancreatic enzymes synergistically damage intestine of rats.Dig Dis Sci. 1998;43:2322-2332.
[PubMed] [DOI]
Kimura RE, Dy SA, Uhing MR, Beno DW, Jiyamapa VA, Lloyd-Still JD. The effects of high-dose ibuprofen and pancreatic enzymes on the intestine of the rat.J Pediatr Gastroenterol Nutr. 1999;29:178-183.
[PubMed] [DOI]
Lloyd-Still JD, Uhing MR, Arango V, Fusaro A, Kimura RE. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat.J Pediatr Gastroenterol Nutr. 1998;26:489-495.
[PubMed] [DOI]
Soma LR, Neufeld GR, Dodd DC, Marshall BE. Pulmonary function in hemorrhagic shock: the effect of pancreatic ligation and blood filtration.Ann Surg. 1974;179:395-402.
[PubMed] [DOI]
De Koos EB, Gibson WJ, Bounous G, Hampson LG. The influence of pancreatic duct ligation on the course of E. coli endotoxin shock in the dog.Can J Surg. 1966;9:227-230.
[PubMed] [DOI]
Smith EE, Crowell JW, Moran CJ, Smith RA. Intestinal fluid loss in dogs during irreversible hemorrhagic shock.Surg Gynecol Obstet. 1967;125:45-48.
[PubMed] [DOI]
Bounous G, Hampson LG, Gurd FN. Cellular Nucleotides in Hemorrhagic Shock: Relationship of Intestinal Metabolic Changes to Hemorrhagic Enteritis and the Barrier Function of Intestinal Mucosa.Ann Surg. 1964;160:650-668.
[PubMed] [DOI]
Norin KE, Gustafsson BE, Midtvedt T. Strain differences in faecal tryptic activity of germ-free and conventional rats.Lab Anim. 1986;20:67-69.
[PubMed] [DOI]
Midtvedt T, Carlstedt-Duke B, Höverstad T, Midtvedt AC, Norin KE, Saxerholt H. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats.Appl Environ Microbiol. 1987;53:2866-2871.
[PubMed] [DOI]
Qin XF. Impaired inactivation of digestive proteases by deconjugated bilirubin: the possible mechanism for inflammatory bowel disease.Med Hypotheses. 2002;59:159-163.
[PubMed] [DOI]
Qin X. Is the incidence of inflammatory bowel disease in the developed countries increasing again? Is that surprising?Inflamm Bowel Dis. 2007;13:804-805.
[PubMed] [DOI]
Qin X. What caused the increase of autoimmune and allergic diseases: a decreased or an increased exposure to luminal microbial components? World.J Gastroenterol. 2007;13:1306-1307.
[PubMed] [DOI]